Usher Syndrome: Promising Preliminary Results from Gene Therapy

01 / 01

An experimental gene therapy developed at the Telethon Institute of Genetics and Medicine (TIGEM) in Pozzuoli has shown encouraging clinical results in patients with Usher syndrome type 1B, a rare genetic disorder that causes congenital deafness and progressive vision loss.

A discovery at SR-Tiget reveals the key liver cells driving organ growth and advancing pediatric gene therapy

Il tuo browser non è più supportato da Microsoft, esegui l'upgrade a Microsoft Edge per visualizzare il sito.